Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.
作者信息
Ismail Sherin, Funk Michele Jonsson, Flythe Jennifer E
机构信息
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina (UNC) at Chapel Hill, Chapel Hill, North Carolina.
UNC Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina.
出版信息
J Am Soc Nephrol. 2024 Aug 1;35(8):1136. doi: 10.1681/ASN.0000000000000386. Epub 2024 May 20.
Abstract
摘要
相似文献
1
Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.作者回复：药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所带来的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1136. doi: 10.1681/ASN.0000000000000386. Epub 2024 May 20.
2
Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所致的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1134-1135. doi: 10.1681/ASN.0000000000000385. Epub 2024 May 20.
3
Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.昂丹司琼与维持性血液透析患者中心性猝死风险。
J Am Soc Nephrol. 2024 Jun 1;35(6):761-771. doi: 10.1681/ASN.0000000000000336. Epub 2024 Feb 27.
4
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.用于减少儿童和青少年急性胃肠炎相关呕吐的止吐药。
Cochrane Database Syst Rev. 2009 Apr 15(2):CD005506. doi: 10.1002/14651858.CD005506.pub4.
5
Antiemetics for reducing vomiting related to acute gastroenteritis in children and adolescents.用于减少儿童和青少年急性胃肠炎相关呕吐的止吐药。
Cochrane Database Syst Rev. 2011 Sep 7;2011(9):CD005506. doi: 10.1002/14651858.CD005506.pub5.
6
7
[5HT3 antagonists: ondansetron].[5-羟色胺3拮抗剂：昂丹司琼]
Rev Med Univ Navarra. 1993 Jan-Mar;38(1):43-9.
8
Ondansetron - falsely accused?昂丹司琼——被错误指控了？
Paediatr Anaesth. 2000;10(3):343.
9
Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.雷莫司琼在外科手术患者中的群体药代动力学及预防性止吐疗效
Br J Clin Pharmacol. 2016 Sep;82(3):762-72. doi: 10.1111/bcp.13010. Epub 2016 Jun 8.
10
Ondansetron looks safe in pregnancy, so far.到目前为止，昂丹司琼在孕期似乎是安全的。
BMJ. 2013 Mar 6;346:f1387. doi: 10.1136/bmj.f1387.
本文引用的文献
1
Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.药代动力学问题可能会影响接受慢性血液透析患者中昂丹司琼所致的心脏风险认知。
J Am Soc Nephrol. 2024 Aug 1;35(8):1134-1135. doi: 10.1681/ASN.0000000000000385. Epub 2024 May 20.
2
Ondansetron and the Risk of Sudden Cardiac Death among Individuals Receiving Maintenance Hemodialysis.昂丹司琼与维持性血液透析患者中心性猝死风险。
J Am Soc Nephrol. 2024 Jun 1;35(6):761-771. doi: 10.1681/ASN.0000000000000336. Epub 2024 Feb 27.
3
Proton pump inhibitors may enhance the risk of citalopram- and escitalopram-associated sudden cardiac death among patients receiving hemodialysis.质子泵抑制剂可能会增加接受血液透析的患者使用西酞普兰和艾司西酞普兰相关的心脏性猝死风险。
Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):670-679. doi: 10.1002/pds.5428. Epub 2022 Mar 24.
Zotero 插件